Giving Cells an Invisibility Cloak
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
65 Results
Clear Filters
New Frontiers in Regenerative Medicine: Highlights of the 2023 NYSCF Conference
Last week we hosted the 18th annual NYSCF Conference at The Rockefeller University, gathering over 500 international participants from academia, industry, government and nonprofits to engage...
She Took it Personally: How a Type 1 Diabetes Diagnosis Inspired Josephine Wesely to Become a Scientist
NYSCF Principal Scientist Josephine (Josi) Wesely, PhD, was probably the only kid who showed up to her doctor’s appointments with scientific papers in hand. “I was...
2022 in Review
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
When Does Type 2 Diabetes Attack the Liver?
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
New Hope for Diabetes: A Discussion with Dr. Simi Ahmed
This November, National Diabetes Month yielded some early holiday cheer as the FDA approved an exciting preventative treatment for type 1 diabetes (T1D). This work was...
The NYSCF Conference Returns in Person to Showcase Seminal Advances in Translational Stem Cell Research
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
Showing Up for Patients: Highlights of the 2022 NYSCF Gala & Science Fair
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
Stem Cell Science in Action: NYSCF Introduces New Drug Discovery Platform at SNF Nostos Conference
“My colleagues and I are delighted to bring the NYSCF lab to you here at SNF Nostos Health today, and to show you in real time...
What are Stem Cells, and How Can They Accelerate Better Treatments for Disease?
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
2021 in Review
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
Translating Discoveries into Medicine, Advancing Equity in Science, and New Cancer Therapies: Watch Highlights of the 2021 NYSCF Conference
On October 19th and 20th, we hosted the sixteenth annual NYSCF Conference on translational stem cell research. This year’s meeting, held virtually for the second consecutive...
The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
Bringing Creative Flair to Stem Cell Research: Meet Kay Unger
NYSCF Board Member Kay Unger may be best known for her eponymous brand and trailblazing career in fashion, but she’s also an inspiring advocate for biomedical...
Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Organoids Just Gained Their Missing Ingredient: Functional Blood Vessels
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NYSCF and Lyfebulb Announce Collaboration on Chronic Disease Research and Education
Lyfebulb, a patient-empowerment platform that connects chronic disease patients, industry, and investors to empower patients and support user-driven innovation, and The New York Stem Cell Foundation...
Four NYSCF Innovators Featured In Nature Article on Embryonic Stem Cell Research
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Cutting-Edge Research Highlights The NYSCF Conference
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...